236O Olaparib (ola) plus bevacizumab (bev) as maintenance (mx) therapy in patients (pts) with newly diagnosed advanced ovarian carcinoma (OC): Japan subset of the PAOLA-1 trial

Keiichi Fujiwara, Isabelle Laure Ray-Coquard, Hiroyuki Yoshida et al.|Annals of Oncology|2020

Cited by 0